Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

GBS - Intelligent Bio Solutions Inc


Previous close
0.4705
0   0%

Share volume: 0
Last Updated: Thu 27 Oct 2022 06:00:00 AM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$0.47
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
2.00%
1 Month
10.48%
3 Months
-30.46%
6 Months
-26.57%
1 Year
-77.78%
2 Year
-95.71%
Key data
Stock price
$0.47
P/E Ratio 
0.00
DAY RANGE
$0.45 - $0.49
EPS 
$0.00
52 WEEK RANGE
$0.36 - $2.89
52 WEEK CHANGE
-$0.77
MARKET CAP 
7.046 M
YIELD 
N/A
SHARES OUTSTANDING 
14.890 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.59
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$28,132
AVERAGE 30 VOLUME 
$71,673
Company detail
CEO:
Region: US
Website: gbs.inc
Employees: 8
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

GBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. With the world-first Biosensor Platform, GBS Inc. is developing and launching diagnostic tests urgently needed to help eradicate COVID-19 and change the lives of people living with diabetes.

Recent news